Yü Xu

Shanghai Jiao Tong University

H指数:15

被引数:1,051

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sestrin2 Exerts a Novel Protective Effect Against LPS-Induced Ferroptosis via the Nrf2-SLC7A11-GPX4 Signaling Axis

Sestrin2通过Nrf2-SLC7A11-GPX4信号轴发挥了一种新颖的保护作用，抵抗LPS诱导的铁死亡。

FASEB JOURNAL

IF4.2

2025-11-260

OAAI

QTL mapping and transcriptome analysis identified BnaA03.XTH4 as a novel negative regulator of plant height in Brassica napus L.

QTL作图和转录组分析鉴定了BnaA03.XTH4为芸薹属（Brassica napus L.）株高的新型负调控因子。

Theoretical and Applied Genetics

IF4.2

2025-06-300

PRE

Global trends in cervical spondylosis research: a bibliometric analysis based on the Web of Science

全球颈椎病研究趋势：基于Web of Science的文献计量分析

FRONTIERS IN NEUROLOGY

IF2.8

2025-04-300

Fruquintinib as first-line or second-line treatment in unresectable or metastatic soft-tissue sarcoma: A prospective, single-arm phase II study

fruquintinib 作为一线或二线治疗不可切除或转移性软组织肉瘤：一项前瞻性、单臂 II 期研究

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2025-04-150

A phase II study of fruquintinib in the 1L or 2L treatment of unresectable metastatic soft tissue sarcoma

fruquintinib 在不可切除的转移性软组织肉瘤的1L或2L治疗中的II期研究

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

Adjuvant Therapy Using Dabrafenib plus Trametinib in Chinese Patients with Resected Stage III Melanoma: A Multicenter Retrospective Cohort Study

DERMATOLOGIC THERAPY

IF3.4

2024-05-240

The role of germanium in diseases: exploring its important biological effects

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2023-11-084

OAAI

A single-arm, phase II clinical trial of neoadjuvant pegylated liposomal doxorubicin plus anlotinib in locally advanced soft tissue sarcoma

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

Phenotypic damage and transcriptomic responses of flower buds in rapeseed (Brassica napus L.) under low-temperature stress

INDUSTRIAL CROPS AND PRODUCTS

IF6.2

2023-08-013

PRE

Tumor Immunophenotyping-Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer

ADVANCED SCIENCE

IF14.1

2023-03-3011

OAAI

TMED3 promotes the development of malignant melanoma by targeting CDCA8 and regulating PI3K/Akt pathway

CELL AND BIOSCIENCE

IF6.2

2023-03-295

OAAI

Diagnostic value of tumor-associated autoantibodies panel in combination with traditional tumor markers for lung cancer

FRONTIERS IN ONCOLOGY

IF3.3

2023-02-158

OAAI

Attenuating endothelial leakiness with self-assembled DNA nanostructures for pulmonary arterial hypertension

用自组装DNA纳米结构减轻内皮细胞渗漏对肺动脉高压的影响

NANOSCALE HORIZONS

IF6.6

2023-01-013

Using machine learning models to predict the duration of the recovery of COVID-19 patients hospitalized in Fangcang shelter hospital during the Omicron BA. 2.2 pandemic

FRONTIERS IN MEDICINE

IF3

2022-11-023

OAAI

Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II

CLINICAL CANCER RESEARCH

IF10.2

2022-10-136

Alternative splicing reprogramming in fungal pathogen Sclerotinia sclerotiorum at different infection stages on Brassica napus

FRONTIERS IN PLANT SCIENCE

IF4.8

2022-10-122

OAAI

Assembling defined DNA nanostructures with anticancer drugs: a metformin/DNA complex nanoplatform with a synergistic antitumor effect for KRAS-mutated lung cancer therapy

用抗癌药物组装定义的DNA纳米结构: 二甲双胍/DNA复合物纳米平台对KRAS突变的肺癌治疗具有协同抗肿瘤作用

NPG ASIA MATERIALS

IF8.3

2022-10-073

Characterization of four spliced isoforms of a transmembrane C-type lectin from Procambarus clarkii and their function in facilitating WSSV infection

FISH & SHELLFISH IMMUNOLOGY

IF3.9

2022-08-019

PRE

Application of Multi-Omics Approach in Sarcomas: A Tool for Studying Mechanism, Biomarkers, and Therapeutic Targets

FRONTIERS IN ONCOLOGY

IF3.3

2022-07-085

OAAI

Extracellular HMGB1 Impairs Macrophage-Mediated Efferocytosis by Suppressing the Rab43-Controlled Cell Surface Transport of CD91

细胞外HMGB1通过抑制CD91的Rab43-Controlled细胞表面转运来损害巨噬细胞介导的胞吞作用

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-03-2213

OAAI

Yü Xu

个人简介

教育背景

工作经历

荣誉奖项

研究方向